Phase I/II clinical trial of idursulfase beta for mucopolysaccharidosis type II
Phase I/II clinical trial of idursulfase beta for mucopolysaccharidosis type II
Patients at the age between 6 months and 15 years with severe type mucopolysaccharidosis type II intravenously administered isursulfase at least for 24 weeks Patients at the age between 6 months and 15 years with severe type mucopolysaccharidosis type II int ...
Intervention type:DRUG. Intervention1:BHP001, Dose form:INJECTION, Route of administration:OTHER.